AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the commencement of an investigator initiated Phase 2 study...
The AI cloud leader H2O.ai announced it and its partner, The Center for Digital Health Innovation (CDHI) at the University of California, San Francisco (UCSF), have been...
Thermo Fisher Scientific Inc, the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for...
